Answers are grounded in this paper and cite their sources.
Preclinical evaluation demonstrates targeted cancer treatment with reduced side effects using platelet-membrane-coated nanoparticles, highlighting their potential for antitumor drug delivery.
Platelet membrane biomimetic nanoparticles played a promising targeted treatment of cancer with low side effect.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: